We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.3B
AUM Growth
-$438M
Cap. Flow
-$385M
Cap. Flow %
-5.28%
Top 10 Hldgs %
23.31%
Holding
3,320
New
46
Increased
2,165
Reduced
525
Closed
74

Top Sells

Rank Stock Value
1
NDAQ icon
Nasdaq
NDAQ
+$90.2M
2
AFL icon
Aflac
AFL
+$85.3M
3
HSY icon
Hershey
HSY
+$53.5M
4
JNJ icon
Johnson & Johnson
JNJ
+$48.8M
5
ABBV icon
AbbVie
ABBV
+$46.6M

Sector Composition

Rank Sector Weight
1 Technology 23.63%
2 Financials 18.4%
3 Healthcare 12.02%
4 Consumer Discretionary 8.91%
5 Industrials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APAM icon
2601
Artisan Partners
APAM
$3B
$2.8K ﹤0.01%
65
+2
+3% +$91
MGRC icon
2602
McGrath RentCorp
MGRC
$2.94B
$2.8K ﹤0.01%
25
ARHS icon
2603
Arhaus
ARHS
$1.34B
$2.79K ﹤0.01%
297
+228
+330% +$2.23K
GCMG icon
2604
GCM Grosvenor
GCMG
$834M
$2.79K ﹤0.01%
227
+173
+320% +$2.06K
NAUT icon
2605
Nautilus Biotechnolgy
NAUT
$110M
$2.78K ﹤0.01%
1,655
+1,501
+975% +$3.59K
COOK icon
2606
Traeger
COOK
$172M
$2.78K ﹤0.01%
23
+21
+1,050% +$3.22K
OSPN icon
2607
OneSpan
OSPN
$603M
$2.76K ﹤0.01%
149
+104
+231% +$1.77K
NARI
2608
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.76K ﹤0.01%
54
VCTR icon
2609
Victory Capital Holdings
VCTR
$6.85B
$2.75K ﹤0.01%
42
VCEL icon
2610
Vericel Corp
VCEL
$2.25B
$2.75K ﹤0.01%
50
PATK icon
2611
Patrick Industries
PATK
$2.75B
$2.74K ﹤0.01%
33
TWST icon
2612
Twist Bioscience
TWST
$7.83B
$2.74K ﹤0.01%
59
TDW icon
2613
Tidewater
TDW
$4.46B
$2.74K ﹤0.01%
50
OSCR icon
2614
Oscar Health
OSCR
$8.54B
$2.73K ﹤0.01%
203
+6
+3% +$97
CCB icon
2615
Coastal Financial
CCB
$743M
$2.72K ﹤0.01%
32
+20
+167% +$1.4K
MRSN
2616
DELISTED
Mersana Therapeutics
MRSN
$2.72K ﹤0.01%
76
+67
+744% +$3.47K
BLUE
2617
DELISTED
bluebird bio
BLUE
$2.71K ﹤0.01%
325
+295
+983% +$2.58K
SIGA icon
2618
SIGA Technologies
SIGA
$210M
$2.71K ﹤0.01%
450
+376
+508% +$2.51K
UEC icon
2619
Uranium Energy
UEC
$5.63B
$2.7K ﹤0.01%
404
-1
-0.2% -$8
SUNS
2620
Sunrise Realty Trust
SUNS
$104M
$2.7K ﹤0.01%
192
+174
+967% +$2.51K
AVAH icon
2621
Aveanna Healthcare
AVAH
$2.06B
$2.69K ﹤0.01%
589
+500
+562% +$2.56K
OII icon
2622
Oceaneering
OII
$5.09B
$2.69K ﹤0.01%
103
HLLY icon
2623
Holley
HLLY
$382M
$2.68K ﹤0.01%
887
+784
+761% +$2.2K
CABA icon
2624
Cabaletta Bio
CABA
$457M
$2.68K ﹤0.01%
1,179
+1,063
+916% +$3.73K
XBIT icon
2625
XBiotech
XBIT
$69.5M
$2.67K ﹤0.01%
677
+618
+1,047% +$4.21K

Similar funds

Sterling Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Sterling Capital Management held 3,320 positions worth $7.3B, down 5.7% from $7.74B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Sterling Capital Management withdrew a net $385M in Q4 2024, closing 74 positions and reducing 525 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $4.12M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Sterling Capital Management opened a new position in iShares Russell 1000 Value ETF worth $10.5M.

  • Sterling Capital Management's largest Q4 2024 buy was iShares Russell 1000 Value ETF: 56,923 shares worth $10.5M.
  • Sterling Capital Management added most to Everest Group in Q4 2024, an estimated $103M increase.
  • Sterling Capital Management's biggest Q4 2024 reduction was Nasdaq, cutting an estimated $90.2M.
  • Sterling Capital Management fully exited iShares Russell 1000 Growth ETF in Q4 2024, selling an estimated $4.12M.
  • Sterling Capital Management's ten largest holdings make up 23% of its $7.3B portfolio in Q4 2024.
  • Sterling Capital Management opened 46 new positions and closed 74 in Q4 2024.
  • Sterling Capital Management's portfolio value fell 5.7% quarter-over-quarter to $7.3B.

Based on Sterling Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.